Patent dispute could be looming. There is a question as to whether the delivery technology could introduce seasonal retroviruses into the food chain, which could limit the scope of such productivity enhancers. I think antibiotic resistance will show up as a heavy negative bias in the trials, rendering the treatment as statistically insignificant. When that happens, watch out below.
Advise to steer clear of this one, or sell into any strength. If it drops below 10 cents, then it could be a speculative buy, class A. Good luck to all.
patent estate
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $373.3M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.2¢ | 4.9¢ | $1.384M | 27.31M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1302118 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 528865 | 4 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |